BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27424777)

  • 1. Lack of age-related clinical progression in PGC-1α-deficient mice - implications for mitochondrial encephalopathies.
    Szalardy L; Molnar M; Torok R; Zadori D; Kovacs GG; Vecsei L; Klivenyi P
    Behav Brain Res; 2016 Oct; 313():272-281. PubMed ID: 27424777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathology of partial PGC-1α deficiency recapitulates features of mitochondrial encephalopathies but not of neurodegenerative diseases.
    Szalardy L; Zadori D; Plangar I; Vecsei L; Weydt P; Ludolph AC; Klivenyi P; Kovacs GG
    Neurodegener Dis; 2013; 12(4):177-88. PubMed ID: 23406886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological comparison of Kearns-Sayre syndrome and PGC-1α-deficient mice suggests a novel concept for vacuole formation in mitochondrial encephalopathy.
    Szalardy L; Molnar M; Torok R; Zadori D; Vecsei L; Klivenyi P; Liberski P; Kovacs GG
    Folia Neuropathol; 2016; 54(1):9-22. PubMed ID: 27179217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of PGC-1α in the pathogenesis of neurodegenerative disorders.
    Róna-Vörös K; Weydt P
    Curr Drug Targets; 2010 Oct; 11(10):1262-9. PubMed ID: 20840068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased mRNA expression of PGC-1α and PGC-1α-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS.
    Thau N; Knippenberg S; Körner S; Rath KJ; Dengler R; Petri S
    J Neuropathol Exp Neurol; 2012 Dec; 71(12):1064-74. PubMed ID: 23147503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Full-length PGC-1α salvages the phenotype of a mouse model of human neuropathy through mitochondrial proliferation.
    Rona-Voros K; Eschbach J; Vernay A; Wiesner D; Schwalenstocker B; Geniquet P; Mousson De Camaret B; Echaniz-Laguna A; Loeffler JP; Ludolph AC; Weydt P; Dupuis L
    Hum Mol Genet; 2013 Dec; 22(25):5096-106. PubMed ID: 23900073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Brown and White Adipocyte Transcriptome by the Transcriptional Coactivator NT-PGC-1α.
    Kim J; Fernand VE; Henagan TM; Shin J; Huypens P; Newman S; Gettys TW; Chang JS
    PLoS One; 2016; 11(7):e0159990. PubMed ID: 27454177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-motor Behavioral Alterations of PGC-1α-Deficient Mice - A Peculiar Phenotype With Slight Male Preponderance and No Apparent Progression.
    Szalardy L; Molnar MF; Zadori D; Cseh EK; Veres G; Kovacs GG; Vecsei L; Klivenyi P
    Front Behav Neurosci; 2018; 12():180. PubMed ID: 30210314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-Specific Deletion of PGC-1α from Medium Spiny Neurons Causes Transcriptional Alterations and Age-Related Motor Impairment.
    McMeekin LJ; Li Y; Fox SN; Rowe GC; Crossman DK; Day JJ; Li Y; Detloff PJ; Cowell RM
    J Neurosci; 2018 Mar; 38(13):3273-3286. PubMed ID: 29491012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy activation, not peroxisome proliferator-activated receptor γ coactivator 1α, may mediate exercise-induced improvements in glucose handling during diet-induced obesity.
    Rosa-Caldwell ME; Brown JL; Lee DE; Blackwell TA; Turner KW; Brown LA; Perry RA; Haynie WS; Washington TA; Greene NP
    Exp Physiol; 2017 Sep; 102(9):1194-1207. PubMed ID: 28639297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biology of PGC-1α and its therapeutic potential.
    Handschin C
    Trends Pharmacol Sci; 2009 Jun; 30(6):322-9. PubMed ID: 19446346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of MPTP on mRNA expression of PGC-1α in mouse brain.
    Torok R; Salamon A; Sumegi E; Zadori D; Veres G; Molnar MF; Vecsei L; Klivenyi P
    Brain Res; 2017 Apr; 1660():20-26. PubMed ID: 28161458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.
    Weydt P; Pineda VV; Torrence AE; Libby RT; Satterfield TF; Lazarowski ER; Gilbert ML; Morton GJ; Bammler TK; Strand AD; Cui L; Beyer RP; Easley CN; Smith AC; Krainc D; Luquet S; Sweet IR; Schwartz MW; La Spada AR
    Cell Metab; 2006 Nov; 4(5):349-62. PubMed ID: 17055784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGC-1α at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond.
    Tsunemi T; La Spada AR
    Prog Neurobiol; 2012 May; 97(2):142-51. PubMed ID: 22100502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA expression levels of PGC-1α in a transgenic and a toxin model of Huntington's disease.
    Török R; Kónya JA; Zádori D; Veres G; Szalárdy L; Vécsei L; Klivényi P
    Cell Mol Neurobiol; 2015 Mar; 35(2):293-301. PubMed ID: 25319408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues.
    Bayer H; Lang K; Buck E; Higelin J; Barteczko L; Pasquarelli N; Sprissler J; Lucas T; Holzmann K; Demestre M; Lindenberg KS; Danzer KM; Boeckers T; Ludolph AC; Dupuis L; Weydt P; Witting A
    Neurobiol Dis; 2017 Jan; 97(Pt A):36-45. PubMed ID: 27818323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial biogenesis is impaired in osteoarthritis chondrocytes but reversible via peroxisome proliferator-activated receptor γ coactivator 1α.
    Wang Y; Zhao X; Lotz M; Terkeltaub R; Liu-Bryan R
    Arthritis Rheumatol; 2015 May; 67(8):2141-53. PubMed ID: 25940958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoform-specific increases in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to beta2-adrenergic receptor activation and exercise.
    Miura S; Kai Y; Kamei Y; Ezaki O
    Endocrinology; 2008 Sep; 149(9):4527-33. PubMed ID: 18511502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells.
    Valle I; Alvarez-Barrientos A; Arza E; Lamas S; Monsalve M
    Cardiovasc Res; 2005 Jun; 66(3):562-73. PubMed ID: 15914121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired coactivator activity of the Gly482 variant of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) on mitochondrial transcription factor A (Tfam) promoter.
    Choi YS; Hong JM; Lim S; Ko KS; Pak YK
    Biochem Biophys Res Commun; 2006 Jun; 344(3):708-12. PubMed ID: 16631115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.